HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristina N Ekdahl Selected Research

Thromboinflammation

1/2021The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
1/2019The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.
11/2016Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation.
4/2016Heparinization of cell surfaces with short peptide-conjugated PEG-lipid regulates thromboinflammation in transplantation of human MSCs and hepatocytes.
1/2016Complement inhibition in biomaterial- and biosurface-induced thromboinflammation.
1/2015Thromboinflammation in Therapeutic Medicine.
10/2014The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies.
1/2013Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristina N Ekdahl Research Topics

Disease

16Inflammation (Inflammations)
06/2022 - 01/2012
8Thromboinflammation
01/2021 - 01/2013
4Autoimmune Diseases (Autoimmune Disease)
01/2019 - 03/2011
3COVID-19
06/2022 - 01/2021
3Wounds and Injuries (Trauma)
12/2021 - 01/2017
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2020 - 05/2007
3Neoplasms (Cancer)
01/2019 - 05/2015
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2015 - 12/2011
2Critical Illness (Critically Ill)
06/2022 - 01/2021
2Thrombosis (Thrombus)
01/2022 - 01/2012
2Vascular Diseases (Vascular Disease)
11/2020 - 06/2020
2Rheumatoid Arthritis
01/2020 - 05/2007
2Infections
01/2019 - 01/2018
2Macular Degeneration (Age-Related Maculopathy)
03/2018 - 01/2017
2Glaucoma
03/2018 - 01/2017
2Uveitis
03/2018 - 01/2017
2Arteriosclerosis
01/2018 - 05/2015
2Multiple Sclerosis
01/2016 - 01/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2015 - 06/2014
2Obesity
09/2015 - 06/2014
2Alzheimer Disease (Alzheimer's Disease)
11/2013 - 01/2013
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Thromboembolism
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Sepsis (Septicemia)
12/2021
1Burns
12/2021
1Acute Disease
12/2021
1Hemolysis
01/2020
1Atypical Hemolytic Uremic Syndrome
10/2019
1Stroke (Strokes)
01/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Death (Near-Death Experience)
12/2018
1Reperfusion Injury
12/2018
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2018
1Retinal Degeneration
03/2018
1Hereditary Complement Deficiency Diseases
01/2018
1Pancreatitis
01/2018
1Disseminated Intravascular Coagulation
01/2018
1Lung Diseases (Lung Disease)
01/2018
1Hypotension (Low Blood Pressure)
01/2018
1Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1Neuromyelitis Optica (Devic's Disease)
01/2017
1Ischemia
01/2016
1Communicable Diseases (Infectious Diseases)
09/2015
1Insulin Resistance
09/2015
1Nausea
02/2015

Drug/Important Bio-Agent (IBA)

22Complement System Proteins (Complement)IBA
01/2022 - 05/2007
6Biomarkers (Surrogate Marker)IBA
06/2022 - 03/2011
4Kallikreins (Kallikrein)IBA
01/2022 - 11/2016
4KininsIBA
01/2022 - 11/2016
4Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2016
3CytokinesIBA
06/2022 - 11/2013
3ChemokinesIBA
01/2022 - 06/2014
3Biocompatible Materials (Biomaterials)IBA
01/2016 - 01/2013
2Immunoglobulin G (IgG)IBA
06/2022 - 01/2019
2complement C3d,gIBA
01/2021 - 05/2007
2Peptide Hydrolases (Proteases)FDA Link
10/2019 - 01/2018
2LipidsIBA
01/2019 - 04/2016
1Immunoglobulin M (IgM)IBA
06/2022
1AntibodiesIBA
06/2022
1Histones (Histone)IBA
06/2022
1Immunoglobulin A (IgA)IBA
06/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1fibrin fragment D (D-dimer)IBA
01/2021
1PrekallikreinIBA
01/2021
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
01/2021
1ApolipoproteinsIBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1SolutionsIBA
01/2020
1Apolipoproteins E (ApoE)IBA
01/2020
1LectinsIBA
10/2019
1LigandsIBA
01/2019
1Therapeutic UsesIBA
01/2019
1FibrinIBA
01/2019
1Factor XII (Hageman Factor)IBA
01/2019
1OligopeptidesIBA
01/2019
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2019
1E-SelectinIBA
01/2019
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Peptides (Polypeptides)IBA
04/2016
1Heparin (Liquaemin)FDA LinkGeneric
04/2016
1Biological ProductsIBA
01/2016
1Complement 3d Receptors (Complement Receptor 2)IBA
01/2016
1AnaphylatoxinsIBA
09/2015
1BradykininIBA
05/2015
1Acetates (Acetic Acid Esters)FDA Link
02/2015

Therapy/Procedure

8Transplantation
01/2019 - 12/2011
5Therapeutics
12/2021 - 10/2014
2Critical Care (Surgical Intensive Care)
06/2022 - 01/2022
1Artificial Respiration (Mechanical Ventilation)
01/2022
1Mechanical Ventilators (Ventilator)
01/2022
1Stents
06/2020
1Homologous Transplantation
01/2019
1Kidney Transplantation
12/2018